Stay informed with the latest litigation news. Explore now

IP Verse

Kymab competitive analysis

Latest publications and patents of Kymab New

Explore the latest publications and patents granted to Kymab, showcasing their recent innovations and technological advancements.

Last updated on: Sep 12, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Kymab

EP3622813
Jun 19, 2024Animal Models And Therapeutic MoleculesPatent Maintained As Amended
EP3028564
Jan 24, 2024Animal Models And Therapeutic MoleculesPatent Maintained As Amended
EP3047022
Dec 27, 2023Expression Vector Production And High-Throughput Cell ScreeningPatent Maintained As Amended
EP2798950
Mar 22, 2023Animal Models And Therapeutic MoleculesPatent Maintained As Amended
EP2792236
Mar 22, 2023Animal Models And Therapeutic MoleculesPatent Maintained As Amended
EP2757875
Mar 22, 2023Manipulation Of Immunoglobulin Gene Diversity And Multi-Antibody TherapeuticsPatent Maintained As Amended
EP2989894
Dec 14, 2022Use Of Fertile Transgenic Animals For Producing Antibodies Bearing Human Variable RegionsGranted And Under Opposition
EP3311661
Apr 20, 2022Manipulation Of Immunoglobulin Gene Diversity And Multi-Antibody TherapeuticsGranted And Under Opposition
EP3241435
May 26, 2021Animal Models And Therapeutic MoleculesGranted And Under Opposition
EP3418379
Dec 9, 2020Methods, Cells & OrganismsRevoked

Latest oppositions filed by Kymab

Explore patent oppositions filed by Kymab against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 18, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3456190
Antibody Producing Non-Human MammalsMERUSAug 19, 2022
EP3626819
Transgenic Mouse Which Produces Hybrid Antibodies Containing Human Variable Regions And Mouse Constant RegionsREGENERON PHARMACEUTICALSDec 22, 2021
EP2738258
Adam6 MiceREGENERON PHARMACEUTICALSJun 25, 2020
EP2578688
Adam6 MiceREGENERON PHARMACEUTICALSMay 4, 2020
EP3085780
Producing Hybrid Antibodies Containing Human Variable Regions And Rodent Constant RegionsREGENERON PHARMACEUTICALSJun 28, 2019
EP3085779
Method Of Modifying Eukaryotic CellsREGENERON PHARMACEUTICALSApr 5, 2019
EP2482849
Combination Immunotherapy For The Treatment Of CancerBOARD OF REGENTSMar 6, 2019
EP2786657
A Method Of Producing An Antibody Comprising A Human Variable Region And A Rodent Constant Region.REGENERON PHARMACEUTICALSNov 7, 2018
EP2786657
A Method Of Producing An Antibody Comprising A Human Variable Region And A Rodent Constant Region.REGENERON PHARMACEUTICALSMar 21, 2018

Latest patents of Kymab opposed by its competitors

Explore Kymab's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 18, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3622813
Jun 19, 2024Animal Models And Therapeutic Molecules1
EP3028564
Jan 24, 2024Animal Models And Therapeutic Molecules1
EP3047022
Dec 27, 2023Expression Vector Production And High-Throughput Cell Screening1
EP2757875
Mar 22, 2023Manipulation Of Immunoglobulin Gene Diversity And Multi-Antibody Therapeutics1
EP2792236
Mar 22, 2023Animal Models And Therapeutic Molecules1
EP2798950
Mar 22, 2023Animal Models And Therapeutic Molecules1
EP2989894
Dec 14, 2022Use Of Fertile Transgenic Animals For Producing Antibodies Bearing Human Variable Regions1
EP3311661
Apr 20, 2022Manipulation Of Immunoglobulin Gene Diversity And Multi-Antibody Therapeutics1
EP3241435
May 26, 2021Animal Models And Therapeutic Molecules1
EP3418379
Dec 9, 2020Methods, Cells & Organisms1

Latest PTAB cases involving Kymab New

Discover the latest PTAB cases involving Kymab, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 18, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Kymab

IPR2025-00605Feb 11, 2025XENCORMERUSPending
IPR2025-00604Feb 11, 2025XENCORMERUSPending
IPR2020-00389Jan 3, 2020REGENERON PHARMACEUTICALSKYMABInstitution Denied
IPR2019-01580Sep 20, 2019REGENERON PHARMACEUTICALSKYMABInstitution Denied
IPR2019-01579Sep 20, 2019REGENERON PHARMACEUTICALSKYMABInstitution Denied
IPR2019-01578Sep 20, 2019REGENERON PHARMACEUTICALSKYMABInstitution Denied
IPR2019-01577Sep 20, 2019REGENERON PHARMACEUTICALSKYMABInstitution Denied

Top competitors of Kymab

Top competitors of Kymab based on patent oppositions.